KVX-053

N/A

Report date: 2025/03/07 14:26:23
NMEFirst In Class

Base Information

Drug NameKVX-053
Drug Alias NameKVX-053JMS-053JMS-631-053
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein tyrosine phosphatase type IVA 3 inhibitors
TargetsProtein tyrosine phosphatase type IVA 3
Therapy Area/IndicationsLung DiseasesOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of PittsburghUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesKeViRx IncUniversity Of Virginia
Inactive CompaniesN/A
Active IndicationsLung DiseasesOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A